T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
73 hedge funds and large institutions have $21.1M invested in T2 Biosystems, Inc in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 12 closing their positions.
24% more call options, than puts
Call options by funds: $470K | Put options by funds: $379K
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
6% less funds holding
Funds holding: 78 → 73 (-5)
25% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 12
39% less capital invested
Capital invested by funds: $34.6M → $21.1M (-$13.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Natixis
Paris,
France
|
+$539K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$166K |
| 3 |
WF
Welch & Forbes
Boston,
Massachusetts
|
+$136K |
| 4 |
Franklin Resources
San Mateo,
California
|
+$111K |
| 5 |
JP Morgan Chase
New York
|
+$55.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$2.66M |
| 2 |
Millennium Management
New York
|
-$2.06M |
| 3 |
GS
Gagnon Securities
New York
|
-$357K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$302K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$126K |
TTOO Hedge Fund Activity: Q3 2021 in Review
73 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2021, worth a combined $21.1M — down 39% from $34.6M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of TTOO and 9 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 13 added.
The largest buyer was Natixis, opening a new position worth an estimated $539K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.66M sold.
- 73 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2021, down from 78 in Q2 2021.
- Funds reported $21.1M of T2 Biosystems, Inc stock for Q3 2021, down 39% quarter-over-quarter.
- 9 funds opened new T2 Biosystems, Inc positions in Q3 2021 and 12 closed out, a net change of -3 holders.
- The largest T2 Biosystems, Inc buyer in Q3 2021 was Natixis, an estimated $539K added.
- The largest T2 Biosystems, Inc seller in Q3 2021 was Renaissance Technologies, an estimated $2.66M sold.
Based on aggregated 13F filings for Q3 2021.